Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2019

01-09-2019 | Glioblastoma | Correction

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma

Authors: Francesco Marampon, Flavio Leoni, Andrea Mancini, Ilaria Pietrantoni, Silvia Codenotti, Letizia Ferella, Francesca Megiorni, Giuliana Porro, Elisabetta Galbiati, Pietro Pozzi, Paolo Mascagni, Alfredo Budillon, Roberto Maggio, Vincenzo Tombolini, Alessandro Fanzani, Giovanni Luca Gravina, Claudio Festuccia

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2019

Login to get access

Excerpt

In the original publication, the 6th author’s first name and the last name was inverted and incorrectly published. The correct author name is Letizia Ferella. …
Metadata
Title
Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma
Authors
Francesco Marampon
Flavio Leoni
Andrea Mancini
Ilaria Pietrantoni
Silvia Codenotti
Letizia Ferella
Francesca Megiorni
Giuliana Porro
Elisabetta Galbiati
Pietro Pozzi
Paolo Mascagni
Alfredo Budillon
Roberto Maggio
Vincenzo Tombolini
Alessandro Fanzani
Giovanni Luca Gravina
Claudio Festuccia
Publication date
01-09-2019
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2019
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-019-02980-6

Other articles of this Issue 9/2019

Journal of Cancer Research and Clinical Oncology 9/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.